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Abstract. The aim of this investigation was to identify 
the domains of type IV collagen participating  in cell 
binding and the cell surface receptor involved. A  ma- 
jor cell binding site was found in the trimeric cyanogen 
bromide-derived fragment CB3, located 100 nm away 
from the NH: terminus  of the molecule, in which the 
triple-helical conformation is stabilized by interchain 
disulfide bridges.  Cell attachment assays with type IV 
collagen and CB3 revealed comparable cell binding ac- 
tivities.  Antibodies against CB3 inhibited attachment 
on fragment CB3 completely and on type IV collagen 
to 80%.  The ability to bind cells was strictly confor- 
mation dependent. 
Four trypsin derived fragments of CB3 allowed a 
closer investigation of the binding  site.  The smallest, 
fully active triple-helical  fragment was (150)3-amino 
acid residues long.  It contained  segments of 27 and 37 
residues, respectively, at the NHe and COOH terminus, 
which proved to be essential for cell binding. 
By affinity chromatography on Sepharose-immobilized 
CB3, two receptor molecules of  the integrin family, otl/31 
and oe2/$1, were isolated. Their subunits were identified 
by sequencing the NH2 termini or by immunoblotting. 
The availability of fragment CB3 will allow for a more 
in-depth study of the molecular interaction of a  short, 
well defined triple-helical ligand with collagen recep- 
tors o¢1/~1 and o~2B1. 
T 
YPE IV collagen is the major collagenous  constituent 
of basement membranes.  It consists  of two al(IV) 
chains and one oe2(IV) chain, each ~1,700 amino acid 
residues long (8). The molecules are 390 nm long with the 
globular NC1 domain found at the COOH terminus.  In the 
extracellular  matrix, type IV collagen forms a complex non- 
fibrillar network. In a manner not completely understood the 
molecules are covalently cross-linked via their NH: termini 
and COOH termini, respectively (45), and also arranged lat- 
erally to form segments of superhelices in which two or three 
triple helices are involved (51). 
This  network,  in which other constituents  of basement 
membranes, such as laminin or heparan sulfate proteoglycan 
are  specifically  incorporated,  acts  as mechanically  stable 
support for cells of the basement membrane zone (44).  In 
vitro experiments  have  shown  that  type IV collagen  is a 
highly specific substrate that interacts with endothelial  (35), 
epidermal  (32),  and  mesenchymal cells  (3,  7),  including 
transformed and metastatic tumor cells (3, 12, 15, 34, 47). 
The cell  surface receptors responsible for the interaction 
with type IV collagen appear to belong mainly to the/$1 or 
VLA  subgroup  of  the  integrin  receptor  family  that  is 
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specifically involved in interactions  with constituents  of the 
extracellular  matrix  (21, 27, 30).  The cell binding  sites of 
type IV collagen are conformation dependent and have been 
ascribed to the triple-helical  domain of the molecule (3), al- 
though some reports describe cell binding to denatured mol- 
ecules as well (39). 
Here we present the isolation of a triple-helical  fragment, 
approximately  (150)3 amino acid residues long and located 
100  nm  away  from  the  NH2  terminus  of the  molecule, 
which contains a major cell binding site of type IV collagen. 
Its triple-helical  conformation is stabilized by intramolecular 
disulfide  bonds  (8,  13).  Polyclonal  antibodies  prepared 
against the fragment inhibited 70-80 % of cell attachment ca- 
pacity to type IV collagen.  Integrins  of the otl/~l and ot2/$1 
type from human tissues  and cell lines bind specifically  to 
this triple-helical  fragment. 
Materials and Methods 
Isolation of 1)2pe IV Collagen 
Tetrameric  type  IV  collagen  was  prepared  according  to  reference 45. 
Minced human placental material (obtained from Behringwerke,  Marburg, 
Germany) from fresh human placenta, washed blood free with 0.4 M so- 
dium chloride, was suspended in 0.5 M acetic acid and treated with porcine 
pepsin (1:2000 [wt/wt];  Boehringer,  Mannheim, Germany) at 4°C for 16 
to 20 h. The protein was precipitated from the supernatant with 0.7 M NaC1, 
again dissolved in 0.03 M Tris/HCl, pH 7.6, containing 0.2 M NaC1, and the 
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NaCI.  For further purification, type IV collagen was dissolved  in 0.03 M 
Tris/HC1,  pH 8.6, containing 2 M urea and 0.2 M  NaCI and applied  to 
DEAE-cellniose (DE52; Whatman Inc., Clifton, N  J) in a batch procedure. 
The nonbinding fraction was dialyzed against 0.1 M acetic acid and lyophi- 
lized. All procedures were carried out at 4"C. In type IV collagen samples 
prepared in this way a part of the methionine residues was oxidized and not 
available  for CNBr cleavage.  To  minimize oxidation of the methionine 
residues,  fresh placenta was used as starting material for the preparation 
of type IV collagen,  and the procedures described above were carried out 
under nitrogen to exclude oxygen as far as possible. 
Intact type IV collagen  from mouse was isolated from the Engelbreth- 
Holm-Swarm tumor by the procedure  of Kleinman et al. (26).  The NH2- 
terminal 7S domain of human type IV collagen was prepared as described 
earlier (28).  The NC1 domain was isolated from human placenta using a 
tv~ step collagenase  treatment described previously  (33). 
Preparation of the CNBr Peptide CB3 
Pepsin-derived  human type IV collagen was dissolved in 70% formic acid 
(10 mg/ml), flushed with nitrogen and incubated with CNBr (protein/CNBr 
1:1 [wt/wt]) for 4 h at 37°C (13). Subsequently, CNBr was removed under 
vacuum overnight; the remaining solution was diluted with 5 volumes of wa- 
ter and lyophilized. 
The CNBr-derived peptide mixture was separated  on an agarose  1.5 m 
column (Bio-Rad Laboratories, Richmond, CA) (5 ×  II0 era) equilibrated 
with 0.05 M Tris/HCl, pH 7.5, containing 1 M CaC12 and 0.02 M sodium 
azide at a flow rate of I00 ml/h. The triple-helical, ttimeric CNBr peptide 
CB3 eluting at a molecular mass range of 80-100 kD was collected  and 
rechromatographed under the same conditions. 
Reduction and Carboxymethylation 
A solution (5-10 rng/ml) of CB3 in 6 M gnanidine.HCl, 0.05 M Tris/HC1, 
pH 8.1, and 0.002 M EDTA, was flushed with nitrogen and placed in a 60°C 
water bath for 30 vain to denature the triple helix. DTT (50 tool per mole 
disulfide) was added, the tube flushed briefly with nitrogen and maintained 
at 50°C for 4 h. After cooling the solution to room temperature,  an aqueous 
iodoacetic acid solution (twofold molar excess over DTT) was added. After 
alkylation for 20 rain in the dark, the reagents  were removed by dialysis 
against 0.1 M acetic acid. 
Preparation of Tryptic Fragments of  CB3 
CB3 was suspended in 0.02 M Tris/HCl, pH 8, at a concentration  of 2 mg/ml 
and heated to 700C for 30 rain to dissolve the protein. To reform the triple- 
helical structure of the fragment, the solution was kept at 20°C overnight. 
Trypsin digestion (trypsin-TPCK;  Worthington  Biochemical  Corp., Free- 
hold, NJ) was performed at 200C for 2 h and terminated by adding acetic 
acid and subsequent lyophilization. 
The tryptic digest was first separated on a TSK 3000 SW ultropac cohmm 
(7.5 x 600mm; Pharmacia-LKB,  Uppsala, Sweden), which was equilibrated 
at a flow rate of 0.15 ml/min with 0.2 M ammonium acetate containing 0.1% 
trifluoroacetic acid. The fragments pooled were further chromatographed  on 
a Mono Q HR 5/5 (Pharmacia) anion exchanger, using 0.02 M Tris/HC1, pH 
8 (solvent  A) and 0.02 M Tris/HCl, pHS, 2 M NaC1 (solvent  B), both  contain- 
ing 2 M urea, at a flow rate of 0.5 ml/min with a gradient of 2.5-16 % B in 50 
min. Fragment 2 was further  purified on a Mono S HR 5/5 (Pharmacia) cation 
exchange column equilibrated with 0.1% trifluoroacetic  acid containing 2 M 
urea, adjusted to pH 2.5 with NaOH (solvent A). Elution was accomplished 
with 0.1% trifluoroacetic  acid, 2 M NaCI, and 2 M urea, pH 2.5 (solvent B), 
using alinear gradient  of  4-25 % B in 30 min at a flow rate of  0.5 ml/min. The 
pooled fragments were dialyzed against 0.5 M acetic acid. 
Analytical Methods 
SDS-PAGE followed established protocols (29).  For molecular mass esti- 
mates, runs were calibrated with globular proteins (Bio-Rad Laboratories) 
and CNBr digests of  type I collagen, under reducing and nonreducing condi- 
tions. For fluorography of gels containing radiolabeled proteins we used Ko- 
dak XAR-5 film. 
Amino acid compositions and protein concentrations were determined 
after hydrolysis with 6 M HCI (24 h, ll0*C) on an analyzer (I.~5001;  Bio- 
tronic Wissensehaft Liche Geriite CsmbH, Puchheim, Germany). 
Amino acid sequences were determined by Edman degradation on a gas 
phase sequencer (model 470A; Applied Biosystems Inc., Foster City, CA) 
either from purified material or from single protein bands transferred to 
polyvinylidene difluoride  membranes (Immobilon; Millipore Continental 
Water Systems, Bedford, MA) (31) by semi-dry eleetroblotting with a Fast- 
Blot apparatus  (Biometra, G6ttingen, Germany) after SDS-PAGE under 
reducing conditions.  The blotting buffer was 50 mM sodium borate at the 
anode and 50 mM sodium borate with 0.1% SDS at the cathode. Both buffers 
contained 10% methanol. Blotting was done at 0.8 mA/cm  2 for 1 h. 
Immunochemical Methods 
Rabbit antisera against CB3 were raised according to standard protocols 
(43) using 500/~g antigen per injection. The IgG fraction of the serum was 
isolated by ammonium sulfate precipitation and subsequent chromatogra- 
phy on protein A-Sepharose or DEAE-cellulose (DE 52; Whatman Inc., 
Clifton, N J). The immunoreactivity of the purified IgG fraction was verified 
by ELISA. 
For the identification of the/~l integrin subunit, the proteins were blot- 
ted onto nitrocellulose  sheets  (Bio-Rad  Laboratories) and then immuno- 
stained as in reference 46. The antiserum against human/~1 isolated from 
blood platelets  was a gift of Dr.  K.  vonder Mark, Erlangen, Germany. 
Cells and Cell Culture 
The following cell lines were used: HTI080 (human fibrosarcoma),  A 375 
(human melanoma), A 431 (human epidermoid), HBL-100 (human mam- 
mary epithelia),  SCL I (human skin carcinoma), SCL 11 (human skin carci- 
noma), Saos-2  (human osteosarcoma), RuGLi  (rat glioblastoma), RN22 
(rat schwannoma) and primary mouse myoblasts (3, 5). Cells were grown 
to coniluency in DMEM, supplemented with glutamine (300/~g/ml),  peni- 
cillin (400 U/ml), streptomycin (50/zg/ml), and 10% FCS (Gibco Labora- 
tories, Grand Island, NY). For propagation and cell attachment assays, ceils 
were harvested with 0.05% trypsin, 0.02% ED'I'A in PBS, pH 7.2. For roller 
bottle cultures (3027; Falcon Labware, Oxnard, CA),  1 mM pyruvate and 
15 mM Hepes were used as additional  supplements. 
Surface Labeling of Cells 
108 ceils grown in roller bottles were pelleted and their surfaces  labeled 
with Na 1z5I (37 Megabequerel sp act 481  MBq/~g, Amersham Buchler, 
GmbH,  Braunschweig,  Germany)  using  Iodo-beads  iodination reagent 
(Pierce  Chemical Company,  Rockford,  IL).  After  labeling,  cells were 
washed three times in TBS, pH 7.2 containing 1 mM each CaC12, MgC12, 
and MnCI2 (wash buffer). 
Attachmen t and Spreading  Assays 
Attachment assays followed the method described by Aumallley et al. (4). 
Tissue culture plates (96 multiwell plates; Costar,  Cambridge, MA) were 
coated by adsorption of the proteins overnight at 4°C. Free binding sites on 
the plastic were blocked with 1% BSA. The amount of protein adsorbed to 
the wells  was determined in separate  experiments by using 125I-labeled 
protein as tracers and counting the radioactivity  after soinbilization  with 
2 M NaOH.  Labeling was performed with iodo-beads  (Pierce  Chemical 
Co.) following the manufacturer's instructions.  The coating  efficiency of 
CB3 and fragments 1--4  was demonstrated to be comparable to that of intact 
collagen type IV from human or mouse (3-5 %). 
Freshly  suspended cells (see above)  in serum-free medium (4  x  105 
cells/ml) were plated onto coated wells (0.1 ml/well) and allowed to attach 
for 30 min at 37°C. For assays carried out in the presence of cycloheximide, 
this was added to culture dishes 2--4 h before testing, and into the attachment 
medium at a concentration of 25 pg/mi. 
At the end of the attachment period, the medium was removed,  the at- 
tached cells were washed with medium, fixed in 70% ethanol and stained 
(41) with 0.1% crystal violet in water (20). After washing extensively with 
distilled water, the dye adsorbed to the cells was solubilized with 0.2% Tri- 
ton X-100 (0.05 ml/well) and optical density was read with an ELISA reader 
(MR 600; Dynatech; Denkendorf, Germany) at 570 urn. A linear correla- 
tion of cell numbers and optical density of released dye has been shown pre- 
viously  (4). 
To assess inhibition  of cell attachment  by antibodies against CB3, protein 
coated dishes were incubated with different dilutions of the antibody in PBS 
for 1 h before adding the cell suspension.  Dilutions of the IgG fraction of 
rabbit nonimmune serum were used as controls, To assess inhibition  of cell 
attachment by synthetic peptides,  equal volumes of cell suspensions were 
mixed with different dilutions of peptides  and added immediately to the 
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triple-helical  CNBr  peptide 
CB3 isolated from pepsin-de- 
rived human type IV collagen. 
Lanes 1 and 4, CB3 from type 
IV collagen with partially oxi- 
dized methionine  residues; lane 
5, CB3 from type IV collagen 
prepared under nitrogen; lane 
2, low molecular mass protein 
standard; lane 3,  CNBr pep- 
tides from type I collagen: (-) 
without  and  (+)  with  DTT. 
Arrows indicate relative molec- 
ular mass values of the CNBr 
peptides from type I collagen. 
Proteins  were  stained  with 
Coomassie brilliant  blue. The 
bands in lanes 4  and 5  were 
blotted  and  characterized  by 
Edman degradation. Numbers 
in brackets denote NHe- and 
COOH-terminal  residues  of 
the individual  peptides. Where- 
as the NH2 termini were directly detected by sequencing, the COOH termini were inferred from the relative molecular mass of the 
polypeptides and the positions of the methionine residues. 
wells (4). Control experiments contained equal amounts of solvent. The 
synthetic peptides used were: GRGDS (Protogen AG, L/iufelfingen, Swit- 
zerland); ARGDPGF, ARGDP*GF (P*  =  hydrooxyproline)  and SRGDTG 
(all peptides were synthesized by Dr. J~ger, Martinsried,  Germany). 
Receptor Extraction from Placenta, Platelets, 
and Cells 
Placenta and platelets were extracted according to (19) with slight modifi- 
cation. Fresh human placenta was freed from chorion and amnion mem- 
branes, cut into small pieces and washed in TBS containing 1 mM MnC12, 
1 mM PMSE 1 ~tg/ml  aprotinin, and 1 t~g/ml  antipain by stirring and filtra- 
tion through a nylon net. The tissue was homogenized in this buffer with 
an Ultraturax and freed from blood and serum proteins by repeated centrifu- 
gation (five times, 1,000  g, 10 min) and resuspension. The insoluble placen- 
tal material was extracted by adding an equal volume of extraction buffer 
(washing buffer containing 50 mM octylglucoside) and stirring for 4-6 h 
at 4°C. After centrifugation at 27000 g for 30 rain, the supernatant was 
stored at  -800C. 
Outdated human platelets  were washed once with 20 mM Tris/HC1, 
pH 8, I mM EDTA, 0.9 % glucose, and centrifugation at 1,000  g for 10 rain. 
The pellet was washed twice with TBS containing 2 mM MgCl2 and pro- 
tease inhibitors as above  by stirring for 1 h at 40C. Finally, the pelleted plate- 
lets were extracted with TBS containing 100 mM octylglucoside, 2 mM 
MgCI2,  1 mM MnCI2, and protease inhibitors. The suspension was cen- 
trifuged at 32,000 g for 30 min. The supernatant was stored at -80"C for 
affinity chromatography. 
Trypsinized ceils were collected by centrifugation (200 g,  10 min) and 
washed three times with TBS containing  2 m_M MgCI2, 1 mM MnCI2, and 
protease inhibitors as above. After pelleting, ceils were extracted with wash 
buffer containing 100 mM octylglueoside (1 ml/ml packed cell volume) for 
20 min  on ice with frequent shaking. Extraction was terminated by centrifu- 
gation (16,000 g, 10 min) (19). 
Receptor Isolation by A~inity Chromatography 
This  is described  in reference  19.  Peptide CB3 was coupled to CNBr- 
activated Sepharose (Pharmacia LKB, Freiburg, Germany) according to the 
manufacturer's  instructions.  The  concentration  of bound CB3  was  3.5 
mg/ml Sepharose. Placental extracts were passed over a CB3-Sepharose 
column (10 ml bed volume) with a flow rate of 5 ml/h.  The column was 
washed with TBS containing 25 mM octylglucoside, 1 mM MnCI2, and 
protease inhibitors as above (80 ml) and then with 20 ml of washing buffer 
containing 300 mM NaC1. Bound protein was eluted with TBS containing 
25 mM octylglucoside, 10 mM EDTA and protease irdaibitors. Finally, the 
column was washed with elution buffer containing 1.85 M NaCI. 
Extracts of cells or platelets were incubated with equal volumes of CB3- 
Sepharose (equilibrated in TBS, 25 mM octylglucoside, 2 mM MgC12, 1 
mM MnC12, and protease inhibitors as above) overnight by rotating at 4°C. 
The Sepharose was then packed into a column (2  x  5 cm) and washed as 
above. Bound protein was eluted with TBS containing 25 mM octylgluco- 
side and 15 mM EDTA. Eluted samples were made 20 mM in MnCI2 to 
inactivate EDTA. 
Column runs were monitored at 280 run. Aliquots of the collected sam- 
ples were precipitated by adding 5 vol of acetone (-20"C). After 10 rain 
precipitates were collected by centrifugation (16,000  g, 10 rain), dried under 
nitrogen, and dissolved in electrophoresis buffer with or without 8 mM DTT 
or 200 mM in mercaptoethanol. 
Results 
Isolation of the Triple-helical Cyanogen Bromide 
Fragment CB3 
As starting material for the isolation of the cell binding site 
we  used  pepsin-derived  type  IV  collagen  from  human 
placenta. This preparation consists of tetramers in which the 
molecules are covalently cross-linked via their NH2 termi- 
nal 7S domains. They contain intact triple-helical domains. 
Only the COOH terminal NC1 domain which was degraded 
by pepsin is missing (45).  CNBr cleavage of the tetrameric 
type IV collagen led to a complex peptide mixture which was 
separated on an Agarose  1.5 m  column (not shown).  Upon 
testing individual peptide fractions in cell attachment assays, 
only one fraction in the range of Mr  =  80-100 kD was ac- 
five. SDS-PAGE of this fraction after rechromatography re- 
vealed triple-helical CNBr peptides in which the individual 
o~-chain fragments were held together by disulfide bridges, 
since several well separated bands appeared after reduction 
(Fig. 1). These reduced bands were characterized by blotting 
and  sequencing  of the  NH2  termini.  The  trimeric  CNBr 
peptide isolated from tetrameric type IV collagen prepared 
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Figure 2. Scheme of the CNBr peptide CB3 and its tryptic frag- 
ments. The triple-helical conformation is stabilized by intramolec- 
ular disulfide bridges. The heterogeneity of CB3 shown in Fig. 1 
(lanes I and 4) is caused by partial oxidation  of  the methionine resi- 
dues 290 and 576 (al) and 407 and 573 (a2),  preventing CNBr 
cleavage. The positions of some of the arginine residues as putative 
trypsin cleavage  sites are indicated. Numbers are the position num- 
bers of  the aligned al(IV) and a2(IV) chains (8). They do not coin- 
cide with residue numbers of the single a-chains. M, methionine; 
C, cysteine; R, arginine; G, glycine; D, aspartic acid; T, threonine; 
P, proline. Disulfide  bridges are tentative. The bars below represent 
the triple helical parts of the four tryptic fragments: fragment 1, 
[al(IV)376-55812ct2(IV)408-554;  fragment 2,  [alflV)431-55812- 
a2(IV)434-554;  fragment  3,  [al(IV)376-52012a2(IV)408-516; 
fragment 4,  [al(IV)431-52012c~2(IV)434-516. Numbers give the 
position of the NH2- and COOH-terminal residue of the individual 
peptides. NH2 termini were directly determined by sequencing, 
COOH termini were inferred from the relative molecular mass 
of the peptides and the potential-trypsin cleavage sites. Sequence 
of the NH2- and COOH-terminal triple-helical segments of frag- 
ment I important for cell attachment is the following.  Position  408- 
433: od(IV), PGERGEKGDRGFPGTSLPGPSGRDGLP;  ot2(IV), 
MGPKGFIGDPGIPALYG-GPPGPDGKR;  and position 51%553: 
¢el(IV), KGDRGLPGRDGVAGVPGPQGTPGLIGQPGAKGE- 
PGEF; a2(IV), KGDKGDPGQHGLPGFPGLKGVPGNIGAPGP- 
KGAKGDS. 
from fresh placenta under conditions where oxidation of  me- 
thionine residues was largely prevented (see Materiais and 
Methods) revealed after reduction the expected monomeric 
peptides CBed(IV) 291-576 and CBot2(IV) 408-573 (Fig. 2, 
Fig.  1, lane 5). An additional band between CBotl(IV) and 
CBoe2(IV) was identified as a COOH-terminal CNBr peptide 
of the oil(l/I) chain which started at position 789 and had a 
220-amino acid residue long triple-helical sequence (2).  It 
arose from a contamination with type III collagen and could 
be removed by chromatography on a Mono Q column. This 
peptide had, in contrast to the entire type III collagen mole- 
cule, no cell binding capacity (not shown). The CNBr peptide 
fraction obtained from tetrameric type IV  collagen with 
partly oxidized methionine residues revealed a peptide mix- 
ture (Fig. 1, lanes I and 4). Beside the expected monomeric 
peptides, the double peptides CBcxl(IV)291-750,  CBal(IV) 
233-576,  and CBot2(IV)300-573  appeared because of in- 
complete cleavage due to a fraction of oxidized methionine 
residues at position 290 and 576 in the or(IV) and 407 in the 
c~2(IV) chain.  For cell attachment experiments only CB3 
preparations with a content of <10% of the double peptides 
were used. 
Trypsin treatment of CB3 preparations and subsequent 
chromatography on a TSK 3000 column resulted in four ma- 
jor peaks containing large fragments (Fig. 3 a). They were 
further purified by ion exchange chromatography on a Mono 
Q column (not shown), and then run on SDS-PAGE without 
and with reduction (Fig. 3 b). The individual bands observed 
were blotted and their exact location along the o~l(IV) and 
c~20V) chain determined by sequence analysis (Fig. 2). 
The Cell Attachment Capacity of the Triple-helical 
Fragment CB3 
Several different  cell lines were tested to compare the cell at- 
tachment capacity of pepsin-derived type IV collagen and 
the  triple-helical  CNBr  peptide  CB3  (see  Materials  and 
Methods). Although the ability to attach to type IV collagen 
varied among different cell lines, the binding activity to type 
IV collagen and the peptide CB3 was comparable for any 
given cell line. No difference could be observed in cell bind- 
ing between pepsin-derived type IV collagen from human 
tissue and intact type IV collagen isolated from the Engel- 
breth-Holm-Swarm mouse tumor (not shown). The experi- 
ments carded out with the human fibrosarcoma cells HT1080 
are described in detail as an example of  the cell lines assayed. 
HT1080 cells show almost identical dose-response profiles 
in their attachment to type IV collagen and peptide CB3 (Fig. 
4). Complete destruction of the triple-helical conformation 
of CB3 by reduction of disulfde bridges under denaturing 
conditions and subsequent carboxymethylation  abolished cell 
attachment. Since unfolded collagenous polypeptides cross- 
linked by covalent bonds easily reform the triple helix, re- 
ductive cleavage of the disulfide bridges was essential for 
complete and irreversible denaturation of CB3 (6,  14). The 
two terminal regions of the type IV collagen molecule, the 
7S  and the  NC1  domain did not show cell binding  (not 
shown). 
The sequence Arg-Gly-Asp (RGD)  is essential for the in- 
teraction of extracellular components such as fibronectin and 
vitronectin with cell receptors of the fll integrin subfamily 
(23, 36). Since otl(IV) and ot2(IV) from human type IV colla- 
gen contain three and seven RGD sequences, respectively (8, 
22), we used RGD containing synthetic peptides in inhibi- 
tion assays of HT1080  cell attachment to type IV collagen 
and CB3.  None of the peptides ARGDPGF, ARGDP*GF, 
SRGDTG, and RGDV, all sequences present in type IV colla- 
gen, inhibited cell attachment. Only the peptide GRGDS, a 
sequence not present in type IV collagen, showed weak in- 
hibitory activity (Fig. 5). However, at a concentration of 500 
#g/ml  that  inhibited  the  attachment  of HT1080  cells  to 
fibronectin almost completely, still >80 % cell attachment to 
type IV collagen and CB3 was observed. 
Polyclonal antibodies raised against CB3 were used to in- 
hibit cell binding to CB3 and type IV collagen. Under condi- 
tions where the attachment of  HT1080 cells to CB3 was com- 
pletely  inhibited,  type  IV  collagen  still  showed  a  cell 
attachment corresponding to 20-30 % of the control (Fig. 6). 
Since the whole antiserum or IgG purified by DEAE chro- 
matography contained components that appeared to mediate 
additional cell attachment, only the IgG fraction purified by 
affinity chromatography on a  protein A  column could be 
used for these experiments. 
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Figure 4.  Ceil binding activity of the triple-helical  CNBr peptide 
CB3 (zx), pepsin-derived  tetrameric type IV collagen (A), and CB3 
reduced under denaturing conditions and carboxymethylated (=). 
Tissue culture multi-well plates were coated with indicated amounts 
of  substrate.  The remaining protein binding sites on the plastic were 
blocked with BSA and the wells were incubated with HTI080 cells 
(4  ×  lff  s cells/well)  at 37°C for 30 rain.  After washing,  the num- 
ber of  cells attached was determined after staining with crystal vio- 
let as described in Materials and Methods. The values  shown are 
the average of triplicates  with blank values  substracted. 
Of the four trypsin-derived fragments of CB3, only frag- 
ment 1, which comprises almost the entire triple-helical part 
of CB3 (see Fig. 2),  showed an attachment capacity similar 
to CB3 (Fig. 7). The smallest fragment, fragment 4, with a 
triple-helical  segment from positions 433 to 516 was, how- 
ever,  inactive  (Fig.  7).  Extension  of the  NH2 terminus  of 
this inactive segment to position 408, as in fragment 3, re- 
stores the cell binding activity to 80% of the value found for 
Figure 3.  Separation and PAGE analysis  of tryptic fragments.  (a) 
Separation of a tryptic digest of the triple-helical  CNBr peptide 
CB3 by molecular sieve HPLC on a TSK 3000 column (7.5  x  600 
mm) equilibrated  with 0.2 M ammonium acetate containing 0.1% 
trifluoroacetic  acid. (b) SDS-PAGE of fragments 1-4 after rechro- 
matography on a Mono Q HR 5/5 column. CB3 (lanes  1 and 6), 
fragment 1 (lanes 2 and 7), fragment 2 (lanes 3 and 8), fragment 
3 (lanes 4 and 9), fragment 4 (lanes 5 and 10).  (-) Without and 
(+) with DTT. Relative molecular mass of the main CNBr-derived 
peptides  are indicated.  The individual  bands of the reduced prepa- 
rations (lanes  6--10)  were blotted and sequenced.  The results  are 
listed  in Fig. 2. 
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Figure 5.  Inhibition of cell  attachment to type IV collagen (A), 
CB3  (A),  and  fibronectin  (e) by the  synthetic  peptide  GRGDS. 
HT1080  (4  x  105 cells/ml)  were mixed with the peptide and 0.1 
ml immediately added to the culture wells coated with 1 pmol pro- 
tein per well.  After incubation at 37°C for 30 min the number of 
cells was determined as described in the legend to Fig. 4. The num- 
ber of cells attached on each substrate  in the absence of GRGDS 
was set to 100%. 
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Figure 6. Inhibition of cell attachment to type IV collagen  and CB3 
by antibodies against CB3. Antibodies were added in indicated dilu- 
tions to the wells coated with 1 pmol of protein and incubated at 
22"C for 1 h before the addition of 4  x  104 HT1080 ceils to each 
well. After 30 rain at 37°C the number of cells attached on each 
substrate was determined as described in the legend to Fig. 4. The 
number  of cells  attached  on each  substrate  in  the absence of 
anti-CB3 IgG was set to 100%. Only IgG purified by DEAE chro- 
matography and affinity chromatography on protein A inhibited 
cell binding to type IV collagen (A) and to CB3 (,x). Purification 
of IgG on a DEAE-cellulose column was not sufficient to remove 
all adventitious serum components mediating cell attachment (o). 
A purified IgG fraction from a rabbit preimmune serum was used 
as control (u). 
fragment 1. Fragment 2, in which the inactive segment is ex- 
tended towards the COOH terminus to position 558 has 40% 
of the cell binding activity of fragment 1. We also measured 
the time dependence of cell attachment at a given protein 
concentration (1 pmol) of CB3 and the trypsin-derived frag- 
ments and confirmed the differences in cell binding activity 
of the trypsin-derived fragments of CB3. The tryptic frag- 
ments 1, 2, and 3 did not only promote attachment but also 
spreading of the HTI080 cells (Fig.  8).  Synthetic peptides 
representing  the  sequence  of  the  NH2-terminal  triple- 
helical  part  of fragment  1  (od(IV)  and  ot2(IV)  positions 
408-433 [Fig. 2]) were used for cell attachment inhibition 
experiments.  Neither the  individual  peptides  nor the  2:1 
mixture of cd(IV) and ct2(IV) peptides showed an inhibition 
effect with up to 20-fold molar excess over the attachment 
substrates. 
IdenU'fication of CeU Receptors of the lntegrin 
Family Responsible  for the Binding of CeUs to the 
Fragment CB3 
HT1080 and Rugli cells, which attached to and spread to a 
comparable extent on type IV collagen and CB3, were ex- 
tracted with an octylglucoside and Mn  2+ containing buffer 
(19). The extracts were passed through an affinity column of 
fragment CB3  immobilized on Sepharose. After washing, 
the column was eluted with EDTA buffer and the eluates sub- 
jected to SDS-PAGE. Both preparations revealed a similar 
polypeptide with an apparent Mr of 116 kD.  After reduc- 
tion, the molecular mass and decreased electrophoretic mo- 
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Figure 7. Comparison of cell binding activity of CB3 (D) with that 
of the trypsin-derived CB3 fragments 1 (&), 2 (e), 3 (o), and 4 
(.). HT1080 cells (4 ×  104 cells/well) were incubated at 37"C for 
30 min. The number of ceils was determined as described in the 
legend to Fig. 4. The tryptic fragments are described in Fig. 2. 
bility of this band resembled that observed for the integrin 
subunit/31 (Fig. 9 a, lanes 5, 6, and 7, 8). In addition, HT1080 
and Rugli cell extracts contained a second component of Mr 
150  and  190  kD,  respectively, resembling  in  their  elec- 
trophoresis mobility the integrin subunits at2 and od (Fig. 9 
a, lanes 5, 6 and 7, 8) (27, 36). In a separate experiment the 
extract of human HBL-100 cells,  surface-labeled with  ~25I 
was applied to a CB3-Sepharose affinity column. The EDTA 
eluate was submitted to SDS-PAGE. Three bands with rela- 
tive molecular mass identical to the od, ct2, and/31  subunlts 
were observed,  suggesting  the  presence of the  el/31  and 
c~2/31 integrins (Fig. 9 b). The two receptors were also iso- 
lated from placenta and blood platelets,  and subjected to 
SDS-PAGE (Fig. 9 a,  lanes 1, 2  and 3, 4).  The separated 
bands were blotted and identified by Edman degradation. 
The amino-terminal sequences determined for the 190- (FN- 
VDVKNSMTF)  and  the  150-kD  (YNVGLPEAKIFSGP) 
band were identical to those of the at1 and t~2 integrin sub- 
units, respectively (24, 40, 41).  Probably due to a blocked 
NH2 terminus, the 120-kD/31  band did not yield a sequence. 
The identity of the/31 subunit was therefore proven by West- 
ern blot analysis with an antiserum against human/31  (not 
shown). The/31 subunits isolated from placenta and plate- 
lets showed slightly different electrophoretic mobilities (Fig. 
9 a, lanes 1, 2 and 3, 4). This seemed to be due to a different 
carbohydrate moiety. After deglycosylation they exhibited 
identical mobility (not shown).  Using immobilized, intact 
murine type IV collagen for affinity chromatography of pla- 
centa and platelet extracts, essentially the same results were 
obtained as with a  CB3 column.  Except for the integrins 
al/31 and tx2/31, no additional type IV collagen-binding trite- 
grins  could be  observed  under  the  conditions  used  (not 
shown). 
Discussion 
Type IV  collagen is  responsible  not only for the macro- 
molecular organization and the biomechanical stability of 
basement  membranes;  along  with  laminin,  nidogen,  and 
heparansulfate proteoglycan it is also involved in the interac- 
The Journal of Cell Biology,  Volume  113,  1991  1480 Figure 8.  Spreading of HT1080  cells on substrates ofCB3 (A) and the tryptic fragments 1 (B), 2 (C), and 3 (D). All wells were coated 
with 4 pmol/well. Pictures were taken after 60 min of exposure to the coats. Bars,  100 #m. 
Figure  9.  SDS-PAGE of type 
IV collagen binding proteins 
purified  by  affinity chroma- 
tography on a CB3-Sepharose 
column.  (a)  Octylglucoside- 
containing cell extracts were 
applied to a CB3 column. Af- 
ter washing, the columns were 
eluted with 10 mM EDTA, ali- 
quots of the eluates were pre- 
cipitated  and  redissolved  in 
the  same buffer without  (-) 
and with (+) DTT.  The pro- 
teins were separated in a 5-12 
(lanes 1-6)or a 7.5% (lanes 7 
and 8) polyacrylamide  gel and 
stained with  silver.  Lanes  1 
and 2, human placenta; lanes 
3 and 4, human platelets; lanes 
5 and 6, rat glioblastoma (Ru- 
Gli); lanes 7and 8, human fi- 
brosareoma (HTI080). Arrows 
indicate  relative  molecular 
mass marker proteins. (b) Hu- 
man mammary epithelial  cells 
were surface labeled with Na 
125I, extracted with octylglu- 
coside, and affinity chromatographed on a CB3-Sepharose column. The 10 mM EDTA eluate was separated on a 7.5% polyacrylamide 
gel with (+) and without (-) DTT and subjected to fluorography. Arrows indicate relative molecular mass of marker proteins. 
Vandenberg et al. Cell Binding Site of Collagen IV  1481 tion of basement membranes with cells (44). The aim of our 
investigations was to identify domains of type IV collagen 
participating in cell binding and the cell surface receptors in- 
volved. We found a (150)3 amino acid residue long triple- 
helical  segment,  ,~100  nm away  from the  NH2-terminal 
end of  the molecule, which appears to possess the major cell- 
binding sites of type IV collagen. Antibodies against CB3, 
which blocked cell binding of the fragment completely, in- 
hibited cell attachment to type IV collagen up to 80%. The 
terminal 7S and NC1 domains did not show cell attachment 
under the  experimental  conditions used.  To  what extent 
other regions of  the triple-helical domain of  the type IV mol- 
ecule interact with cells is not clear, since we failed to pre- 
pare larger triple-helical segments that did not contain the 
CB3 region. 
Affinity chromatography of cell extracts with the immobi- 
lized CB3 fragment was used to identify the cell receptors 
involved in type IV collagen binding. Two different integrin 
types, cd/~l  and a2/31,  were found to interact specifically 
with CB3. These two integrins are the typical collagen recep- 
tors (27, 37, 48). They mediate cell binding to type I as well 
as to type IV collagen, and there are reports that at least 
a2/~l interact also with types 1I, HI and VI collagen (38, 48). 
In addition,  it has been  found that al/~l  and a2/~l  have 
affinity for laminin (10, 18, 25). Thus ligand binding of these 
two integrins does not appear to be very specific.  Whether 
this is due to a  binding domain with an extremely broad 
specificity or to the presence of several distinct, more spe- 
cific domains, is not known. 
In our experiments, the binding of CB3 to both integrins 
was strictly dependent on the triple-helical conformation. 
There are, however, reports that integrins also interact with 
denatured collagen. This may be due to the fact that the se- 
quence RGD occurs relatively frequently in the triple-helical 
areas of collagen. After unfolding of the triple helix, RGD 
sequences become exposed and may then be able to interact 
with different integrins such as a5/31, ot,/~l, or a~b/~3 ave3, 
known as RGD-dependent fibronectin or vitronectin recep- 
tors (1). However, in intact triple helices the glycine residues, 
which occupy every third position along the peptide chains, 
are hidden in the center of the helix and are not accessible 
for receptors. A typical example is type VI collagen (3). The 
native molecules with an intact triple-helical domain interact 
with cells in a RGD-independent manner. The unfolded in- 
dividual o~ chains of  type VI collagen also bind cells, but now 
cell binding can be inhibited by RGD-containing synthetic 
peptides. The question is whether interaction of cells with 
unfolded collagen is physiologically relevant. It can be as- 
sumed that in vivo, denatured collagen will be removed by 
proteolytic enzymes relatively rapidly and that it is present 
in the extracellular matrix only in negligible amounts. In this 
respect it is striking that cell attachment to the triple-helical 
fragment CB3 can be inhibited up to 20 % by 500 #g/rnl syn- 
thetic peptide RGDS, in spite of the fact that it does not con- 
tain a RGD sequence. Thus inhibition of cell attachment in 
the presence of high amounts of RGD containing synthetic 
peptides may lead to unspecific results. 
Cell binding to the four trypsin derived fragments of CB3 
revealed two  sequence  regions important for binding the 
a2~l  containing HT1080  cells  ,,o50 ran away from each 
other,  whereby the NH2-terminal site appeared to be the 
more important one.  Experiments with isolated integrins 
will be necessary to decide whether a2/31 interacts with two 
neighboring triple-helical segments or whether additional 
collagen binding proteins at the surface of the HTI080 cells 
are involved.  Synthetic peptides with the od(IV) and a2(IV) 
sequences of the NHz-terminal cell binding site of CB3 did 
not show any binding or inhibitory effect, neither in large 
molar excess, nor in mixtures. This corroborates our finding 
that the activity to interact with cells is strongly dependent 
on  the  triple-helical  structure  and  that both polypeptide 
chains are important constituents of the binding site. 
Recently it has been reported (9) that a synthetic peptide 
of 15 amino acid residues, representing an al0V) sequence 
located near the COOH-terminal end of  the triple-helical do- 
main of the type IV collagen molecule, promoted adhesion 
and spreading of  a murine melanoma cell. Another synthetic 
peptide with a sequence of al(IV) in the vicinity of the CB3 
fragment seemed to promote attachment of human keratino- 
cytes (50).  In both cases the cell receptors are unknown. 
Staatz et al. (39) have observed that the a2/~l integrin, which 
is responsible for the Mg+2-dependent adhesion of platelets 
to type I collagen, interacts not only with the triple-helical 
type I collagen molecule, but also with the unfolded cd(I) 
and a2(I) chains and the  147-residues  long CNBr peptide 
al(I)CB3. In earlier experiments (16) it was shown that adhe- 
sion of platelets to type I and HI collagen depends on the 
triple-helical conformation. Only one CNBr peptide of type 
HI collagen, ,10II)CB4, in location and sequence homolo- 
gous to al(I)CB3, also revealed platelet adhesion activity, 
but in comparison to the activity of the triple-helical mole- 
cule only in a 500-1,000-fold molar excess.  Comparison of 
the sequences of al(I)CB3 and od(III)CB4 with the amino 
acid sequence of the ,10V) and a20N) chains of fragment 
CB3 did not reveal an obvious homology. 
The question arises whether the cell binding site of the 
CB3 region, discovered in soluble collagen molecules is also 
accessible to cells in type IV collagen when it is incorporated 
in the extracellular matrix. There is evidence that the CB3 
region is accessible in tissue. Treatment of human placenta 
and murine Engelbreth-Holm-Swarm tumor tissue with bac- 
terial collagenase at 20°C cleaves the type IV collagen mole- 
cule only at one site in the NH2-terminal vicinity of the cell 
binding site in CB3 (49).  In mouse type IV collagen the ini- 
tial cut occurs between Pro (390) and Gly (391) (Mann, K., 
A.  Ries,  and K.  Kiihn, unpublished results).  Similar col- 
lagenase treatment of dissolved type IV collagen molecules 
causes additional cleavages at several other regions of the 
triple-belical domain. It is interesting that the cleavage site 
of the mammalian metalloproteinase collagenase IV is also 
located close to the NH2-terminal area of CB3 (17). 
The close proximity of the cell binding site as well as the 
cleavage site of collagenase IV may be used by invading tu- 
mor cells  to penetrate basement membranes.  Having at- 
tached to the collagen network via the cell binding site of 
CB3,  the  tumor cells  secrete  type IV  collagenase which 
hydrolyzes type IV collagen in the CB3 area (11, 42). This 
could result in the destruction of the cell binding site as well 
as produce local degradation of the collagen IV  network 
whereupon the cells detach themselves from type IV colla- 
gen and penetrate basement membranes at the sites of pro- 
teolysis. 
The isolation of a relatively short and stable triple-helical 
segment, which bears the binding site for the typical collagen 
The JourrlaJ of Cell Biology, Volume  113, 1991  1482 receptors cdB1 and o~2B1, provides for the first time the op- 
portunity to investigate in more detail those regions of the 
od, c~2, and B1 subunits of integrins which are responsible 
for the interaction with a stiff,  rod-like collagen  ligand. 
We wish to thank Dr.  Monique Aumailley for helpful discussions. 
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